
Recent Articles
Government Money Should Set Moderna Stock Back on the Path to Growth
By
Todd Shriber, InvestorPlace Contributor
Yes, Moderna is advanced, relative to many rivals, in its efforts to bring a Covid-19 vaccine to market. However, the combination of the gravity of this situation – industries, jobs and most importantly, human lives, hang in the balance – and the timeline of getting a treatment to market make for a situation where upside in MRNA stock is unlikely to be linear.
3 Monthly Dividend Stocks in Danger
By
Todd Shriber, InvestorPlace Contributor
Monthly dividend stocks appeal to income investors, but plenty of members of this group are at risk of negative dividend action.
7 OTC Stocks Perfect for Ordinary Investors
By
Todd Shriber, InvestorPlace Contributor
Some OTC stocks are big, familiar names with credible business models and powerful brands. Investors shouldn't pass on this exciting space.
Stay Clear of Exxon Mobil Stock as It Struggles to Protect the Dividend
By
Todd Shriber, InvestorPlace Contributor
Speaking of oil prices, the recovery hasn't been sharp enough to prevent Exxon from issuing some gloomy commentary. In a recent regulatory filing, the oil major said that if prices don't rally some more – it didn't say by how much – before the end of 2020, it could be forced to write-off 20% of output, or the equivalent of 4.5 billion barrels of crude.
Etsy Has the Makings of Long-Term E-Commerce Winner
By
Todd Shriber, InvestorPlace Contributor
ETSY stock is one of the brightest stars in online retail this year, but investors shouldn't focus on masks. There's more to like here.

Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.